Sickle Cell Disease Treatment Market Size is Projected to Garner USD 1.6 Billion by 2031

As per the report published by Allied Market Research, the global sickle cell disease treatment market generated $1.1 billion in 2021, and is expected to reach $1.6 billion by 2031, growing at a CAGR of 4.1% from 2022 to 2031. The report provides an in-depth analysis of top segments, changing market trends, value chains, key investment pockets, competitive scenarios, and regional landscape. The report is an essential and helpful source of information for leading market players, investors, new entrants, and stakeholders in formulating new strategies for the future and taking steps to strengthen their position in the market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭- https://www.alliedmarketresearch.com/request-sample/31900

𝐃𝐫𝐢𝐯𝐞𝐫𝐬

Rise in prevalence of sickle cell disease

Surge in government support for healthcare infrastructure improvement

Increase in R&D initiatives

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬

Rise in investment by key players toward R&D related to sickle cell diseases

𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬

High cost of treatment associated with sickle cell diseases and their side effects

𝐂𝐨𝐯𝐢𝐝-19 𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨:

The Covid-19 pandemic negatively affected the market due to decline in hospitalization, ER visits, decrease in people who received routine follow-up care from a hematologist, and duration of stay.
The outbreak of Covid-19 disrupted the workflows in the healthcare. It forced several industries to shut their businesses.
However, the market is expected to recover post-pandemic as the governments launched several vaccination drives.
The report segments the global sickle cell disease treatment market on the basis of drug type, type, route of administration, and region.

Based on drug type, the hydroxyurea segment held the largest share in 2021, accounting for more than three-fifths of the market. However, the adakveo segment is estimated to register the highest CAGR of 5.9% during the forecast period.

On the basis of type, the sickle cell anemia segment held the largest share in 2021, accounting for more than half of the market. In addition, the segment is expected to showcase the highest CAGR of 4.7% from 2022 to 2031.

Based on route of administration, the oral segment accounted for the largest share in 2021, holding around four-fifths of the market. However, the parenteral segment is projected to manifest the highest CAGR of 4.3% during the forecast period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/31900

The global sickle cell disease treatment market is analyzed across several regions such as North America, LAMEA, Asia-Pacific, and Europe. The market across North America held the lion's share in 2021, accounting for around two-fifth of the market. However, the market across Asia-Pacific is expected to register the highest CAGR of 5.7% from 2022 to 2031.

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐬𝐢𝐜𝐤𝐥𝐞 𝐜𝐞𝐥𝐥 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐬 𝐚𝐧 𝐢𝐧-𝐝𝐞𝐩𝐭𝐡 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐫𝐢𝐦𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐬𝐮𝐜𝐡 𝐚𝐬
Agios Pharmaceuticals,
Bristol Myers Squibb Company,
CRISPR Therapeutics,
Editas Medicine,
Emmaus Life Sciences, Inc.,
Global Blood Therapeutics, Inc.,
Medunic USA, Inc.,
Novartis AG, N
ovo Nordisk,
and Vifor Pharma.

The report analyzes these key players in the global sickle cell disease treatment market. These players have adopted various strategies such as new product launches, expansion, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments of every market player.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.alliedmarketresearch.com/sickle-cell-disease-treatment-market-A31450

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧
Digestive Health Market https://www.alliedmarketresearch.com/digestive-health-market-A31458

𝐍𝐨𝐬𝐞 𝐑𝐞𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/nose-reconstruction-market-A13217

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.